Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Canadian Journal of Microbiology
Cagrilintide acetate can be used in obesity studies
Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, Durkalski V, Larson AM, Liou I, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Smith A, Brown R, Crippin J, Harrison ME, Koch D, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hassanein T, Hanje AJ, Olson J, Subramanian R, Karvellas C, Hameed B, Sherker AH, Robuck P, Lee WM
This test evaluates how your body responds to GLP-1 receptor signaling and other peptide pathways, informing whether semaglutide alone, combination therapy with metformin, or alternative compounds like tirzepatide may serve you best
doi: 10.1016/0165-1781(95)02656-h 191
Five participants withdrew from the trial, including four in the placebo arm (two participants did not provide a reason for withdrawal, one participant did not have a weight loss response, and the remaining participant withdrew due to adverse event (AE) reasons)
